Literature DB >> 850433

Prognosis of patients after open mitral commissurotomy. Actuarial analysis of late results in 100 patients.

L B Housman, L Bonchek, L Lambert, G Grunkemeier, A Starr.   

Abstract

The continuing controversy between proponents of open and closed commissurotomy might be clarified by analysis of late follow-up with modern actuarial techniques that provide a true perspective of patient risk. We have used open mitral commissurotomy exclusively for 15 years in 100 patients. There was one operative death from pancreatitis and one late death from cancer; the actuarially projected survival rate (+/- the standard error) at 10 years is 97 per cent (+/- 2). Thirteen patients had preoperative emboli, 6 of whom were in sinus rhythm and 7 in atrial fibrillation. Two patients had postoperative emboli, both in sinus rhythm. The actuarial chance of remaining free of embolism at 10 years is 97 per cent (+/- 2). Sixteen patients required reoperation on the mitral valve for functional deterioration. The remaining survivors were in Class I or II when last seen. The actuarial chance of not requiring a reoperation after 5 years is 91 per cent (+/- 4) and at 10 years, 38 per cent(+/- 16). Results in different centers are difficult to compare for many reasons, but imprecise statistical methods further obscure such comparisons. The use of actuarial techniques may help to define the role of open mitral commissurotomy.

Entities:  

Mesh:

Year:  1977        PMID: 850433

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  The surgery of mitral stenosis 1898-1948: why did it take 50 years to establish mitral valvotomy?

Authors:  T Treasure; A Hollman
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

2.  Open mitral valvotomy: fourteen years' experience.

Authors:  P H Kay; P Belcher; K Dawkins; S C Lennox
Journal:  Br Heart J       Date:  1983-07

3.  Late clinical and echocardiographic follow up after percutaneous balloon dilatation of the mitral valve.

Authors:  C E Ruiz; H P Zhang; H Gamra; J W Allen; F Y Lau
Journal:  Br Heart J       Date:  1994-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.